It is a healthcare private limited company based in Seri Lingampally, Telangana, India, established in 2019.
2019 | Seri Lingampally, Telangana, India | ActiveGiclinics Private Limited, a active private limited company, was established on 26 November 2019 in Seri Lingampally, Telangana, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U85100TG2019PTC137153. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹3.02 M.
Its leadership includes Priyanka Manne (Director), Saikrishna Katepally (Director), Babireddy Sivananda Reddy (Director). It holds ₹2.92 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No. 201, Surya Arcade, Behind Labonel Fine Baking, Cyberhills Colony, P Janardhan Reddy Nagar, Seri Lingampally, Telangana, 500032.
U85100TG2019PTC137153
137153
26 November 2019
₹5.00 M
₹3.02 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Giclinics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priyanka Manne | Director | 26 Nov 2019 | Current |
| Saikrishna Katepally | Director | 26 Nov 2019 | Current |
| Babireddy Sivananda Reddy | Director | 17 Nov 2020 | Current |
| Rohan Reddy Proddutoor | Director | 26 Nov 2019 | Current |
| Mudumala Issac Abhilash | Director | 26 Nov 2019 | Current |
| Kiran Kumar Peddi | Director | 17 Nov 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Giclinics Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2021, Giclinics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,920,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2024 | Others | ₹1.92 M | Open |
| 29 Feb 2024 | Others | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Giclinics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Giclinics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Giclinics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 1.92 M with Charge ID 100995133 was registered on 29 Oct 2024. was documented.
The activity Giclinics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Giclinics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
A charge with Others amounted to Rs. 1.00 M with Charge ID 100895591 was registered on 29 Feb 2024. was recorded as a recent event.
Babireddy Sivananda Reddy was appointed as a Director was appointed as a Director on 17 Nov 2020 & has been associated with this company since 5 years 14 days . was recorded as a recent event.
The activity Kiran Kumar Peddi was appointed as a Director was appointed as a Director on 17 Nov 2020 & has been associated with this company since 5 years 14 days . was completed.
The CIN of Giclinics Private Limited is U85100TG2019PTC137153.
Giclinics Private Limited is headquartered at Unit No. 201, Surya Arcade, Behind Labonel Fine Baking, Cyberhills Colony, P Janardhan Reddy Nagar, Seri Lingampally, Telangana, 500032.
Giclinics Private Limited was incorporated on 26 November 2019.
The current directors of Giclinics Private Limited are
The primary industry of Giclinics Private Limited is Hospital And Medical Care.
Giclinics Private Limited is unlisted.
The authorized capital of Giclinics Private Limited is ₹5.00 M, and the paid-up capital is ₹3.02 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX